Investigational Site — Charlotte, North Carolina

Investigational Site is a clinical research site located in Charlotte, North Carolina, United States 28210.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigational Site has participated in 12 clinical trials.

Therapeutic areas: Rheumatoid Arthritis, Relapsed or Refractory Chronic Lymphocytic Leukemia, Postherpetic Neuralgia.

Sponsors: Ablynx, a Sanofi company, Cyclacel Pharmaceuticals, Inc., Purdue Pharma LP.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site?

Investigational Site has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site conducted?

Investigational Site has 12 clinical trials on record. Their work covers Rheumatoid Arthritis, Relapsed or Refractory Chronic Lymphocytic Leukemia, Postherpetic Neuralgia.

Is Investigational Site accredited by Crixeo Health?

Yes — Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.